Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297750 · ClinicalTrials.gov registry record · NA
Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT02297750: Completed NA study, sponsored by Duke University.
NCT02297750 is a NA study that has completed, run by Duke University. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02297750, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible.
Primary Outcome
The primary outcome is incidence of successful deep biliary cannulation within 10 minutes.
Interventions
- PROCEDURE double-wire technique in patients undergoing ERCP with biliary cannulation
- PROCEDURE single-wire technique in patients undergoing ERCP with biliary cannulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02297750 record still lists
NCT02297750 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which double-wire technique in patients undergoing ERCP with biliary cannulation is the first listed.
NCT02297750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02297750 about?
NCT02297750 is a clinical study titled "Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP". The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible.
What is the current status of trial NCT02297750?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2012-08. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02297750?
The interventions under investigation include: double-wire technique in patients undergoing ERCP with biliary cannulation (PROCEDURE), single-wire technique in patients undergoing ERCP with biliary cannulation (PROCEDURE).
Who is sponsoring clinical trial NCT02297750?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02297750's enrollment target sits among peer trials
161 628th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia